Practical System of Assessment: An Updated Acronym for PSA

References 

1. Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65:965
   • Abstract
   • Full Text
   • Full-Text PDF (223 KB)
   • CrossRef
2. Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Urology. 2006;67:316
   • Abstract
   • Full Text
   • Full-Text PDF (101 KB)
   • CrossRef
3. National Comprehensive Cancer Network: 2004 Practice Guidelines in Oncology. Available at: http://www.nccn.org/professionals/physican_gls/PDF/prostate_detection.pdfology. Accessed July 24, 2005.
4. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11
   • MEDLINE
   • CrossRef
5. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. JAMA. 2005;294:433
   • CrossRef